A Practical Guide to the Recognition and Management of Myasthenia Gravis (original) (raw)

• Engel AG. Myasthenia gravis and myasthenic syndromes. Ann Neurol 1984; 16: 519–34
  Article PubMed CAS Google Scholar
• Evoli A, Tonali P, Bartoccioni E, et al. Ocular myasthenia gravis: diagnostic and therapeutic problems. Acta Neurol Scand 1988; 77: 31–5
  Article PubMed CAS Google Scholar
• Newsom-Davis J, Willcox N, Schluep M, et al. Immunologic heterogeneity and cellular mechanisms in myasthenia gravis. Ann NY Acad Sci 1987; 505: 12–26
  Article PubMed CAS Google Scholar
• Oosterhuis HJGH. Myasthenia gravis: clinical neurology and neurosurgery monographs. Edinburgh: Churchill Livingstone, 1984
  Google Scholar
• Oh SJ, Cho HK. Edrophonium responsiveness not necessarily diagnostic of myasthenia gravis. Muscle Nerve 1990; 13: 187–91
  Article PubMed CAS Google Scholar
• Phillips LH, Melnick PA. Diagnosis of myasthenia gravis in the 1990s. Semin Neurol 1990; 10: 62–9
  Article PubMed Google Scholar
• Howard JF, Sanders DB, Massey JM. The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. Neurol Clin 1994; 12(2): 305–30
  PubMed Google Scholar
• Sanders DB, Howard JT. AAEE minimograph no. 25: single-fiber electromyography in myasthenia gravis. Muscle Nerve 1986; 9: 809–19
  Article PubMed CAS Google Scholar
• Lindstrom J. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol 1977; 7: 36–43
  Article PubMed CAS Google Scholar
• Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985; 48: 1246–52
  Article PubMed CAS Google Scholar
• Limburg PC, The TH, Hummel-Tappel E, et al. Anti-acetylcholine receptor antibodies in myasthenia gravis: pt 1. Relation to clinical parameters in 250 patients. J Neurol Sci 1983; 58: 357–70
  Article PubMed CAS Google Scholar
• Engel AG. Congenital myasthenic syndromes. Neurol Clin 1994; 12(2): 401–37
  PubMed CAS Google Scholar
• Vincent A, Li Z, Hart A, et al. Seronegative myasthenia gravis: evidence for plasma factor(s) interfering with acetylcholine receptor function. Ann NY Acad Sci 1993; 681: 529–38
  Article PubMed CAS Google Scholar
• Drachman DB. Myasthenia gravis. N Engl J Med 1994; 330: 1797–810
  Article PubMed CAS Google Scholar
• Sanders DB, Scoppetta C. The treatment of patients with myasthenia gravis. Neurol Clin 1994; 12(2): 343–68
  PubMed CAS Google Scholar
• Ricciardi R, Rossi B, Nicora M, et al. Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation. J Neurol Neurosurg Psychiatry 1991; 54: 1061–2
  Article PubMed CAS Google Scholar
• Abramsky O, Aharonov A, Teitelbaum D, et al. Myasthenia gravis and acetylcholine receptor: effect of steroids on clinical course and cellular immune response to AChR. Arch Neurol 1975; 32: 684–7
  Article PubMed CAS Google Scholar
• Tindall RSA. Humoral autoimmunity in myasthenia gravis: effects of steroids and thymectomy. Neurology 1980; 30: 554–7
  Article PubMed CAS Google Scholar
• Sommer N, Melms A, Weiler M, et al. Ocular myasthenia gravis: a critical review of clinical and pathophysiological aspects. Doc Ophtalm 1993; 84: 309–33
  Article CAS Google Scholar
• Haward CWH, Fonseca V. New treatment approaches to myasthenia gravis. Drugs 1990; 39: 66–73
  Article Google Scholar
• Johns TR. Long-term corticosteroid treatment in myasthenia gravis. Ann NY Acad Sci 1987; 505: 568–83
  Article PubMed CAS Google Scholar
• Evoli A, Batocchi AP, Palmisani MT, et al. Long-term results of corticosteroid therapy in patients with myasthenia gravis. Eur Neurol 1992; 32: 37–43
  Article PubMed CAS Google Scholar
• Hohlfeld R, Toyka KV, Besinger UA, et al. Myasthenia gravis: reactivation of clinical disease and autoimmune factors after discontinuation of long-term azathioprine. Ann Neurol 1985; 17: 238–42
  Article PubMed CAS Google Scholar
• Matell G. Immunosuppressive drugs: azathioprine in the treatment of myasthenia gravis. Ann NY Acad Sci 1987; 505: 589–94
  Article PubMed CAS Google Scholar
• Osterman PO. Current treatment of myasthenia gravis. Prog Brain Res 1990; 84: 151–61
  Article PubMed CAS Google Scholar
• Hohlfeld R, Michels M, Heininger K, et al. Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis. Neurology 1988; 38: 258–61
  Article PubMed CAS Google Scholar
• Niakan E, Harati Y, Rolak LA. Immunosuppressive drug therapy in myasthenia gravis. Arch Neurol 1988; 43: 155–6
  Article Google Scholar
• Wiederrecht G, Lam E, Hung S, et al. The mechanism of action of FK 506 and cyclosporine A. Ann NY Acad Sci 1993 Nov 30; 696: 9–19
  Article PubMed CAS Google Scholar
• Tindall RS, Phillips JT, Rollins JA, et al. A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann NY Acad Sci 1993 Jun 21; 681: 539–51
  Article PubMed CAS Google Scholar
• Perlo VP, Shahani BT, Huggins CE, et al. Effect of plasmapheresis in myasthenia gravis. Ann NY Acad Sci 1981; 377: 709–24
  Article PubMed CAS Google Scholar
• Tindall RSA. Plasmapheresis for neurologic disorders. Curr Neurol 1990; 10: 177–93
  Google Scholar
• Heininger K, Hartung HP, Toyka KV, et al. Therapeutic plasma exchange in myasthenia gravis: selective adsorption of anti-AChR autoantibodies with tryptophane-linked polyvinyl-alcohol gels. Ann NY Acad Sci 1987; 505: 898–900
  Article Google Scholar
• Antozzi C, Berta E, Confalonieri P, et al. Protein A immunoadsorption in immunosuppression-resistant myasthenia gravis. Lancet 1994; 343: 124
  Article PubMed CAS Google Scholar
• Cosi V, Lombardi M, Piccolo G, et al. Treatment of myasthenia gravis with high-dose intravenous immunoglobulin. Acta Neurol Scand 1991; 84: 81–4
  Article PubMed CAS Google Scholar
• Arsura EL, Bick A, Brunner NG, et al. High dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Intern Med 1986; 146: 1365–8
  Article PubMed CAS Google Scholar
• Evoli A, Palmisani MT, Bartoccioni E, et al. High-dose intravenous immunoglobulin in myasthenia gravis. Ital J Neurol Sci 1993; 14: 233–7
  Article PubMed CAS Google Scholar
• Tan E, Hajinazarian M, Bay W, et al. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol 1993; 50: 137–9
  Article PubMed CAS Google Scholar
• Ahlberg R, Yi Q, Pirskanen R, et al. Clinical improvement of myasthenia gravis by treatment with a chimeric anti-CD4 monoclonal antibody. Ann NY Acad Sci 1993; 681: 552–5
  Article PubMed CAS Google Scholar
• Donaldson DH, Ansher M, Rutherford RB, et al. The relationship of age to outcome in myasthenia gravis. Neurology 1990; 40: 786–90
  Article PubMed CAS Google Scholar